SHENZHEN, China, Dec 31, 2012 /PRNewswire-FirstCall/ -- Mindray Medical International Limited ("Mindray", NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present in four upcoming investor conferences and events.
Ms. May Li, Mindray's Deputy Chief Financial Officer, and Ms. Cathy Gao, Mindray's Investor Relations Manager, will attend the 31st Annual J.P. Morgan Healthcare Conference to be held January 7-11, 2013 at the Westin St. Francis Hotel in San Francisco. Ms. Li will present at 11:00 am PST on Wednesday, January 9, and will meet with investors from January 7 to January 9.
On January 7, Ms. Li and Ms. Gao will also participate in the 2nd Annual China Healthcare Dinner with C-Level Executives co-hosted by Elsevier Business Intelligence, KPCB China, Oppenheimer & Co. and Western Bridge in San Francisco.
Next will be the UBS Greater China Conference 2013, to be held January 14-16 at the Pudong Shangri-La Hotel in Shanghai. Mindray's President and CEO, Mr. Li Xiting, and Ms. May Li will attend the conference on January 14.Mr. Li and Ms. May Li will also participate in the 11th Annual DB Access China Conference to be held January 14-15, 2013 at the Grand Hyatt Hotel in Beijing. Mr. Li and Ms. May Li will present at 9:00 am HKT on Tuesday, January 15, and will meet with investors on the same day. About Mindray Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China, we supply through our worldwide distribution network a broad range of products across three primary business segments, namely patient monitoring and life support, in-vitro diagnostic, and medical imaging systems. For more information, please visit http://ir.mindray.com. For investor and media inquiries, please contact:
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts